Geller Advisors LLC
- SEC CIK
- 0001354739
- Latest filing
- Feb 14, 2025
VRTX holding history
Vertex Pharmaceuticals Inc in every 13F filed by Geller Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRTX overviewAll 13F holders of VRTXFull Q4 2024 holdings
- Shares (Q4 2024)
- 586
- Value
- $236.0K
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 586 | $236.0K | <0.1% | −1,434−71.0% | Reduced | Holders |
| Q3 2024 | 2,020 | $939.5K | 0.1% | −754−27.2% | Reduced | Holders |
| Q2 2024 | 2,774 | $1.30M | 0.1% | −38−1.4% | Reduced | Holders |
| Q1 2024 | 2,812 | $1.18M | 0.1% | −17−0.6% | Reduced | Holders |
| Q4 2023 | 2,829 | $1.15M | 0.1% | +109+4.0% | Added | Holders |
| Q3 2023 | 2,720 | $945.9K | 0.1% | −105−3.7% | Reduced | Holders |
| Q2 2023 | 2,825 | $994.1K | 0.1% | +921+48.4% | Added | Holders |
| Q1 2023 | 1,904 | $599.9K | 0.1% | −13−0.7% | Reduced | Holders |
| Q4 2022 | 1,917 | $553.6K | 0.1% | +75+4.1% | Added | Holders |
| Q3 2022 | 1,842 | $533.0K | 0.1% | −56−3.0% | Reduced | Holders |
| Q2 2022 | 1,898 | $535.0K | 0.1% | +1,898 | New | Holders |